StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Rockwell Medical total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Rockwell Medical's total debt was $9.00M at Jun 30, 2026. For fiscal 2025 it was $8.83M, up 4.2% from the year before. The highest annual figure on record is $20.95M in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.83M+4.2%
FY2024Dec 31, 2024$8.47M+2.2%
FY2023Dec 31, 2023$8.29M-9.7%
FY2022Dec 31, 2022$9.19M-55.3%
FY2021Dec 31, 2021$20.57M-1.8%
FY2020Dec 31, 2020$20.95M–
FY2019Dec 31, 2019$0-100.0%
FY2013Dec 31, 2013$20.23M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$9.00M+4.1%
Q1 FY2026Mar 31, 2026$8.91M+4.1%
Q4 FY2025Dec 31, 2025$8.83M+4.2%
Q3 FY2025Sep 30, 2025$8.74M+4.2%
Q2 FY2025Jun 30, 2025$8.65M+4.3%
Q1 FY2025Mar 31, 2025$8.56M+3.6%
Q4 FY2024Dec 31, 2024$8.47M+2.2%
Q3 FY2024Sep 30, 2024$8.38M-6.5%
Q2 FY2024Jun 30, 2024$8.30M-11.5%
Q1 FY2024Mar 31, 2024$8.27M-10.9%
Q4 FY2023Dec 31, 2023$8.29M-9.7%
Q3 FY2023Sep 30, 2023$8.96M-36.4%
Q2 FY2023Jun 30, 2023$9.37M-39.5%
Q1 FY2023Mar 31, 2023$9.28M-49.6%
Q4 FY2022Dec 31, 2022$9.19M-55.3%
Q3 FY2022Sep 30, 2022$14.09M-33.6%
Q2 FY2022Jun 30, 2022$15.50M-26.7%
Q1 FY2022Mar 31, 2022$18.41M-12.5%
Q4 FY2021Dec 31, 2021$20.57M-1.8%
Q3 FY2021Sep 30, 2021$21.23M+1.8%
Q2 FY2021Jun 30, 2021$21.13M+1.8%
Q1 FY2021Mar 31, 2021$21.04M+1.7%
Q4 FY2020Dec 31, 2020$20.95M–
Q3 FY2020Sep 30, 2020$20.86M–
Q2 FY2020Jun 30, 2020$20.76M–
Q1 FY2020Mar 31, 2020$20.68M–
Q4 FY2019Dec 31, 2019$0–

More Rockwell Medical figures

See a number that looks wrong?